This is a preview of subscription content, log in via an institution to check access.
Reference
Lasa JS, et al. Safety of S1P Modulators in Patients with Immune-Mediated Diseases: A Systematic Review and Meta-Analysis. Drug Safety : 5 Mar 2021. Available from: URL: http://doi.org/10.1007/s40264-021-01057-z
Rights and permissions
About this article
Cite this article
Systematic review: S1P modulators in immune-mediated diseases. Reactions Weekly 1847, 10 (2021). https://doi.org/10.1007/s40278-021-92567-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-92567-3